License Agreements in the Pharmaceuticals Industry

1,201 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (5 contracts)
Accelerated Pharma, Inc. (2)
ACELRX PHARMACEUTICALS INC (2)
Acer Therapeutics Inc. (9)
Aclaris Therapeutics, Inc. (3)
ACURA PHARMACEUTICALS, INC (6)
Adamis Pharmaceuticals Corp (12)
ADIAL PHARMACEUTICALS, INC. (8)
Aegerion Pharmaceuticals, Inc. (6)
AEON Biopharma, Inc. (2)
Aerpio Pharmaceuticals, Inc. (5)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (1)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (2)
ALDER BIOPHARMACEUTICALS INC (2)
Alexza Pharmaceuticals Inc. (4)
ALIMERA SCIENCES INC (1)
ALSERES PHARMACEUTICALS INC (9)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (4)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (1)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (2)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (2)
ANGIOTECH PHARMACEUTICALS INC (8)
ANI Pharma Inc (10)
Anthera Pharmaceuticals Inc (1)
APRICUS BIOSCIENCES, INC. (8)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (1)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (5)
Arog Pharmaceuticals, Inc. (3)
ARTELO BIOSCIENCES, INC. (10)
Artemis Therapeutics, Inc. (2)
ARVINAS, INC. (6)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (5)
Astex Pharmaceuticals, Inc (5)
ATAI Life Sciences B.V. (3)
Atea Pharmaceuticals, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (17)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (2)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (1)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (9)
Bakhu Holdings, Corp. (5)
BARR PHARMACEUTICALS INC (2)
Baudax Bio, Inc. (6)
Bausch Health Companies Inc. (1)
BENTLEY PHARMACEUTICALS INC (1)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
Biofrontera Inc. (6)
Biohaven Ltd. (3)
BioNumerik Pharmaceuticals, Inc. (2)
BioPharmX Corp (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (5)
BRADLEY PHARMACEUTICALS INC (1)
Braeburn Pharmaceuticals, Inc. (1)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (2)
Canbiola, Inc. (1)
Cancer Prevention Pharmaceuticals, Inc. (4)
Cannabics Pharmaceuticals Inc. (3)
CANNAPOWDER, INC. (1)
Cantabio Pharmaceuticals Inc. (1)
Cara Therapeutics, Inc. (7)
CASSAVA SCIENCES INC (5)
CELGENE CORP (1)
Cerecor Inc. (9)
Charlotte's Web Holdings, Inc. (7)
CinCor Pharma, Inc. (1)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (11)
Clearside Biomedical, Inc. (14)
CNS Pharmaceuticals, Inc. (1)
Cocrystal Pharma, Inc. (6)
COLLEGIUM PHARMACEUTICAL, INC (1)
CoLucid Pharmaceuticals, Inc. (2)
Context Therapeutics Inc. (2)
ContraVir Pharmaceuticals, Inc. (1)
CorMedix Inc. (4)
COSMO VENTURES INC (7)
CPEX Pharmaceuticals, Inc. (1)
CUBIST PHARMACEUTICALS INC (10)
CUMBERLAND PHARMACEUTICALS INC (2)
CymaBay Therapeutics, Inc. (4)
Dermata Therapeutics, Inc. (2)
Dova Pharmaceuticals Inc. (1)
DURECT CORP (23)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (6)
Elanco Animal Health Inc (2)
ELITE PHARMACEUTICALS INC (20)
Elixir Pharmaceuticals, Inc. (4)
Eloxx Pharmaceuticals, Inc. (17)
Endo International plc (4)
Endo Pharmaceuticals Solutions Inc. (10)
EPIX Pharmaceuticals, Inc. (5)
Eton Pharmaceuticals, Inc. (3)
Evofem Biosciences, Inc. (2)
Evolus, Inc. (8)
EYEGATE PHARMACEUTICALS INC (9)
EYENOVIA, INC. (7)
EyePoint Pharmaceuticals, Inc. (4)
EYETECH PHARMACEUTICALS INC (3)
Fulcrum Therapeutics, Inc. (3)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (4)
Harmony Biosciences Holdings, Inc. (1)
HARROW HEALTH, INC. (10)
Horizon Pharma plc (21)
Hoth Therapeutics, Inc. (7)
IDENIX PHARMACEUTICALS INC (7)
Ikena Oncology, Inc. (2)
IMAGING3 INC (2)
IMARA Inc. (5)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (1)
Innovive Pharmaceuticals, Inc. (3)
INSPIRE PHARMACEUTICALS INC (7)
IntelGenx Technologies Corp. (1)
Intra-Cellular Therapies, Inc. (4)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (1)
Iterum Therapeutics plc (1)
Jaguar Health, Inc. (8)
Jazz Pharmaceuticals plc (14)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (13)
Kala Pharmaceuticals, Inc. (5)
Kannalife Inc (2)
KING PHARMACEUTICALS INC (5)
KOS PHARMACEUTICALS INC (2)
Lannett Company, Inc. (3)
Level Brands, Inc. (6)
Lexaria Bioscience Corp. (16)
Lipocine Inc. (3)
Liquidia Corp (3)
Longboard Pharmaceuticals, Inc. (3)
Lowell Farms Inc. (1)
Luckwel Pharmaceuticals Inc. (3)
Lumena Pharmaceuticals, Inc. (3)
MAP Pharmaceuticals, Inc. (4)
MARINUS PHARMACEUTICALS INC (2)
MAXIM PHARMACEUTICALS INC (2)
Medicine Man Technologies, Inc. (4)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (5)
MiddleBrook Pharmaceuticals, Inc. (1)
MIRA PHARMACEUTICALS, INC. (3)
MJ Holdings, Inc. (2)
Molecular Insight Pharmaceuticals, Inc. (13)
MYnd Analytics, Inc. (1)
Nabriva Therapeutics plc (3)
NEKTAR THERAPEUTICS (4)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (3)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (3)
NEXIEN BIOPHARMA, INC. (2)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (15)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (16)
OCULAR THERAPEUTIX, INC (4)
Odonate Therapeutics, Inc. (1)
OMEROS CORP (10)
Omthera Pharmaceuticals, Inc. (2)
OncoMed Pharmaceuticals Inc (13)
Onconova Therapeutics, Inc. (3)
ONYX PHARMACEUTICALS INC (1)
OPIANT PHARMACEUTICALS, INC. (11)
OPTIMER PHARMACEUTICALS INC (2)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (1)
Organon & Co. (1)
OSCIENT PHARMACEUTICALS CORP (8)
OSI PHARMACEUTICALS INC (6)
Osmotica Pharmaceuticals plc (1)
OTONOMY, INC. (2)
PANACOS PHARMACEUTICALS, INC. (3)
Paratek Pharmaceuticals, Inc. (19)
PaxMedica, Inc. (4)
PEAK PHARMACEUTICALS, INC. (1)
Petros Pharmaceuticals, Inc. (3)
Phathom Pharmaceuticals, Inc. (3)
Phoenix Life Sciences International Limited. (1)
Pivot Pharmaceuticals Inc. (2)
PLx Pharma Inc. (7)
PONIARD PHARMACEUTICALS, INC. (2)
PREDIX PHARMACEUTICALS HOLDINGS INC (2)
PRESTWICK PHARMACEUTICALS INC (2)
Processa Pharmaceuticals, Inc. (10)
ProPhase Labs, Inc. (2)
PROTEO INC (2)
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
Provention Bio, Inc. (7)
Pulmatrix, Inc. (5)
QUARK PHARMACEUTICALS INC (14)
QUATRX PHARMACEUTICALS CO (6)
QUESTCOR PHARMACEUTICALS INC (1)
Quoin Pharmaceuticals, Ltd. (1)
Ra Pharmaceuticals, Inc. (2)
RADIENT PHARMACEUTICALS Corp (6)
Rain Therapeutics Inc. (3)
Rani Therapeutics Holdings, Inc. (4)
REATA PHARMACEUTICALS INC (22)
Recro Pharma, Inc. (8)
Reliant Pharmaceuticals, Inc. (10)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (8)
resTORbio, Inc. (10)
Revance Therapeutics, Inc. (7)
Rib-X Pharmaceuticals, Inc. (6)
ROCK CREEK PHARMACEUTICALS, INC. (1)
Roivant Sciences Ltd. (2)
SALIX PHARMACEUTICALS LTD (13)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
Scopus BioPharma Inc. (7)
scPharmaceuticals Inc. (1)
SCYNEXIS INC (11)
SenesTech, Inc. (1)
SHAMAN PHARMACEUTICALS INC (1)
Somanta Pharmaceuticals Inc. (1)
Sonoma Pharmaceuticals, Inc. (9)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (4)
Supernus Pharmaceuticals, Inc. (8)
Synovics Pharmaceuticals (1)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (5)
TAURIGA SCIENCES, INC. (4)
Telomir Pharmaceuticals, Inc. (2)
Terns Pharmaceuticals, Inc. (3)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (2)
Textmunication Holdings, Inc. (1)
TFF Pharmaceuticals, Inc. (3)
The Medicines Company (1)
TherapeuticsMD, Inc. (4)
Theravance Biopharma, Inc. (3)
Theseus Pharmaceuticals, Inc. (1)
TITAN PHARMACEUTICALS INC (4)
Trevi Therapeutics, Inc. (4)
Tribute Pharmaceuticals Canada Inc. (3)
United Cannabis Corp (1)
Urigen Pharmaceuticals, Inc. (5)
Urovant Sciences Ltd. (3)
Valera Pharmaceuticals Inc (4)
Vallon Pharmaceuticals, Inc. (1)
Verrica Pharmaceuticals Inc. (1)
VIA Pharmaceuticals, Inc. (6)
Virpax Pharmaceuticals, Inc. (6)
Vitality Biopharma, Inc. (3)
VIVUS INC (7)
Wave Life Sciences Ltd. (3)
WEED, INC. (1)
Zoetis (5)
ZOGENIX, INC. (5)
Zomedica Pharmaceuticals Corp. (5)

Recent Contracts

Amended and Restated Intellectual Property License Agreement with Premier Anti-Aging Co., Ltd. dated March 15, 2024 (Lexaria Bioscience Corp., Filed With SEC on April 9, 2024)
License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Zomedica Pharmaceuticals Corp., Filed With SEC on April 1, 2024)
Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd (OMEROS CORP, Filed With SEC on April 1, 2024)
Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd (OMEROS CORP, Filed With SEC on April 1, 2024)
License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010 (OMEROS CORP, Filed With SEC on April 1, 2024)
Binding Memorandum of Understanding for Amendment to Exclusive License Agreement and Transitional Manufacturing and Supply Agreement, dated as of December 26, 2023, by and between... (SCYNEXIS INC, Filed With SEC on March 28, 2024)
Exclusive License Agreement (with Equity), dated March 21, 2024, by and between the Company and University of Miami (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on March 27, 2024)
License Agreement Dated June 15, 2023 by and between Star Brands and Medicine Man Technologies, Inc (Medicine Man Technologies, Inc., Filed With SEC on March 27, 2024)
Third Amendment to License and Supply Agreement dated February 6, 2024 between Harrow IP, LLC and Sintetica S.A (HARROW HEALTH, INC., Filed With SEC on March 19, 2024)
License Agreement, effective as of March20, 2024, by and between cbdMD, Inc. and HSKL, Inc (Level Brands, Inc., Filed With SEC on March 18, 2024)
License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Liquidia Corp, Filed With SEC on March 13, 2024)
Fourth Amendment to License Agreement, by and among the Registrant, Emory University and The Georgia Tech Research Corporation, dated January 31, 2024 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
License Agreement, by and between the Registrant and BioCryst Pharmaceuticals, Inc., dated as of November 1, 2023 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
License, Supply, and Distribution Agreement (Europe), dated as of December 20, 2024, by and between Evolus Pharma B.V. and Symatese Aesthetics S.A.S (Evolus, Inc., Filed With SEC on March 7, 2024)
Second Amendment to License and Supply Agreement, dated as of July 15, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Evolus, Inc., Filed With SEC on March 7, 2024)
First Amendment to License and Supply Agreement, dated as of February 26, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Evolus, Inc., Filed With SEC on March 7, 2024)
License Agreement dated January 12, 2024 by and among Lipocine, Inc., Gordon Silver Limited, and Verity Pharmaceuticals (Lipocine Inc., Filed With SEC on March 7, 2024)
Second Amendment to Development and License Agreement dated March 21, 2023, dated as of December 10, 2023, by and between Hangzhou Highlightll Pharmaceutical Co. Ltd. and Biohaven... (Biohaven Ltd., Filed With SEC on February 29, 2024)
Second Amended and Restated License and Supply Agreement, dated February 19, 2024, between the Company, Pharma and Bioscience (Biofrontera Inc., Filed With SEC on February 20, 2024)
Amended and Restated Addendum to Amended and Restated License and Supply Agreement, dated January 29, 2024 (Biofrontera Inc., Filed With SEC on February 2, 2024)
License and Distribution Agreement by and between NovaBay and Sonoma, dated, January 5, 2024 (NovaBay Pharmaceuticals, Inc., Filed With SEC on January 10, 2024)
License and Distribution Agreement, dated January 5, 2024, by and between Sonoma Pharmaceuticals, Inc. and NovaBay Pharmaceuticals, Inc (Sonoma Pharmaceuticals, Inc., Filed With SEC on January 9, 2024)
Addendum to Amended and Restated License and Supply Agreement, dated as of December 12, 2023 (Biofrontera Inc., Filed With SEC on December 15, 2023)
Exclusive License Agreement, by and between the Company and MIRALOGX, dated as of November 30, 2023 (MIRA PHARMACEUTICALS, INC., Filed With SEC on November 20, 2023)
Amendment No. 1 to Amended and Restated License Agreement, dated November 10, 2023, by and between Telomir Pharmaceuticals, Inc. and MIRALOGX LLC (Telomir Pharmaceuticals, Inc., Filed With SEC on November 14, 2023)
Amended and Restated License Agreement, dated August 11, 2023, by and between Telomir Pharmaceuticals, Inc. and MIRALOGX LLC (Telomir Pharmaceuticals, Inc., Filed With SEC on November 14, 2023)
Second Amended and Restated License Agreement, dated as of August 31, 2023, between Journey Medical Corporation and Maruho Co., Ltd (Journey Medical Corp, Filed With SEC on November 13, 2023)
License Agreement, dated as of August 31, 2023, between Journey Medical Corporation and Maruho Co., Ltd (Journey Medical Corp, Filed With SEC on November 13, 2023)
License Agreement, dated August 15, 2023, by and between Eyenovia, Inc. and Formosa Pharmaceuticals, Inc (EYENOVIA, INC., Filed With SEC on November 13, 2023)
Second Amendment to License and Supply Agreement, dated August 4, 2023, between Harrow IP, LLC and Sintetica S.A (HARROW HEALTH, INC., Filed With SEC on November 13, 2023)
License Agreement, dated as of May 1, 2020, between Bayon Therapeutics, Inc. and the Regents of the Un (EYEGATE PHARMACEUTICALS INC, Filed With SEC on November 9, 2023)
License Agreement, effective as of July 5, 2023, by and between the Registrant and CAMP4 Therapeutics Corporation (Fulcrum Therapeutics, Inc., Filed With SEC on November 7, 2023)
Form of License Agreement (Lowell Farms Inc., Filed With SEC on October 12, 2023)
License and Distribution Agreement, by and between the Company and Farma Mondo (certain provisions of this exhibit have been omitted pursuant to Regulation S-K, Item... (Quoin Pharmaceuticals, Ltd., Filed With SEC on September 13, 2023)
Exclusive License Agreement dated as of August 28, 2023 by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AB (Acer Therapeutics Inc., Filed With SEC on August 31, 2023)
Biological Materials License Agreement, dated August 26, 2019, by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute and... (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
Exclusive License Agreement, dated August 5, 2019, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
Exclusive License Agreement, dated November 11, 2020, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
Exclusive Patent License Agreement, dated as of June 18, 2020, by and between the U.S. Department of Health and Human Services, as represented by the National Institute of Allergy... (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
License Agreement, dated as of April 28, 2023, by and between VYNE Therapeutics Inc. and Tay Therapeutics Limited (Menlo Therapeutics Inc., Filed With SEC on August 14, 2023)